Description
Aimovig (erenumab) is a monoclonal antibody that targets the CGRP receptor for the preventive treatment of migraine.
$675.00
CGRP receptor antibody for migraine
Aimovig (erenumab) is a monoclonal antibody that targets the CGRP receptor for the preventive treatment of migraine.
Reviews
There are no reviews yet.